Therapeutic considerations for postprandial dyslipidaemia

被引：6

作者：

Burnett, TR

Watts, GF

机构：

[1] Univ Western Australia, Royal Perth Hosp, Univ Dept Med, Perth, WA 6001, Australia

[2] Royal Perth Hosp, Div Lab Med, Dept Core Clin Pathol & Biochem, Perth, WA, Australia

来源：

DIABETES OBESITY & METABOLISM | 2001年 / 3卷 / 03期

关键词：

D O I：

10.1046/j.1463-1326.2001.00155.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：143 / 156

页数：14

共 151 条

[31] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].

Downs, JR ;

Clearfield, M ;

Weis, S ;

Whitney, E ;

Shapiro, DR ;

Beere, PA ;

Langendorfer, A ;

Stein, EA ;

Kruyer, W ;

Gotto, AM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622

[32] Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia [J].

Ellen, RLB ;

McPherson, R .

AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A) :60B-65B

[33] REDUCED LIPOLYSIS OF LARGE APO-E POOR VERY LOW-DENSITY-LIPOPROTEIN SUBFRACTIONS FROM TYPE-IV HYPERTRIGLYCERIDEMIC SUBJECTS INVITRO AND INVIVO [J].

EVANS, AJ ;

WOLFE, BM ;

STRONG, WLP ;

HUFF, MW .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (01) :105-115

[34] A clinical trial of the use of Sibutramine for the treatment of patients suffering essential obesity [J].

Fanghänel, G ;

Cortinas, L ;

Sánchez-Reyes, L ;

Berber, A .

INTERNATIONAL JOURNAL OF OBESITY, 2000, 24 (02) :144-150

[35]

FOGER B, 1994, CLIN INVESTIGATOR, V72, P294

[36]

FOGER B, 1993, CURR OPIN LIPIDOL, V4, P428

[37]

Frick MH, 1997, CIRCULATION, V96, P2137

[38] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].

FRICK, MH ;

ELO, O ;

HAAPA, K ;

HEINONEN, OP ;

HEINSALMI, P ;

HELO, P ;

HUTTUNEN, JK ;

KAITANIEMI, P ;

KOSKINEN, P ;

MANNINEN, V ;

MAENPAA, H ;

MALKONEN, M ;

MANTTARI, M ;

NOROLA, S ;

PASTERNACK, A ;

PIKKARAINEN, J ;

ROMO, M ;

SJOBLOM, T ;

NIKKILA, EA .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245

[39] Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis [J].

Fruchart, JC ;

Duriez, P ;

Staels, B .

CURRENT OPINION IN LIPIDOLOGY, 1999, 10 (03) :245-257

[40]

Gerdes C, 1997, CIRCULATION, V96, P733

← 1 2 3 4 5 6 7 8 9 10 →